New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
05:55 EDTAVEO, AVEO, CAH, CAH, ABC, ABC, AET, AET, CVS, CVS, BMY, BMY, JPM, JPM, MCK, MCK, CLSN, CLSNCBI to host a forum
6th Annual Forum on Oncology Market Access & Payer Strategies is being held in Philadelphia on January 30-31.
News For MCK;CLSN;AVEO;CAH;ABC;AET;CVS;BMY;JPM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 26, 2015
12:02 EDTAETAetna, MemorialCare announce accountable care collaboration in California
Subscribe for More Information
08:32 EDTCVSCVS Health to partner with telehealth providers to improve patient care
Subscribe for More Information
August 25, 2015
16:06 EDTJPMOptions Update; August 25, 2015
Subscribe for More Information
16:01 EDTCVSTarget sees $550M pretax gain after closing CVS transaction
Subscribe for More Information
14:20 EDTJPMFormer JPMorgan analyst charged in $600,000 insider trading scheme
Subscribe for More Information
12:20 EDTJPMOn The Fly: Top stock stories at midday
Subscribe for More Information
11:12 EDTJPMNumerous analysts upgrade Bank of America amid market rebound
Subscribe for More Information
10:21 EDTCAHCardinal Health to acquire majority stake in naviHealth
Cardinal Health announced that it is acquiring a majority stake in naviHealth and expects the transaction to close later this week. Privately-held naviHealth partners with health plans, health systems and providers to manage the post-acute segment of the care continuum. naviHealth's principal investor, Welsh, Carson, Anderson & Stowe, along with management, will continue to have an ownership interest in the business. Cardinal Health said it is acquiring 71% of naviHealth for approximately $290M, with a goal of acquiring the entire business within four years, in accordance with a series of call/put rights during that period of time. Cardinal expects this acquisition to be neutral to its FY16 non-GAAP diluted earnings per share from continuing operations as it is a partial period, and slightly accretive to non-GAAP diluted earnings per share from continuing operations beginning in FY17, the first full year post close. "From a GAAP perspective, it is too early in the process to provide any specific guidance on the amortization of intangible assets. Once the fair value estimates are complete, we will provide additional details. Recall that our FY16 assumptions provided on our earnings call on July 30, 2015 only included those acquisitions that had been completed through June 30," the company stated in an FAQ document related to the deal.
10:03 EDTJPMChase, Enterprise Car Sales announce multi-year private-label agreement
Subscribe for More Information
09:59 EDTJPMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:35 EDTJPMActive equity options trading on open
Subscribe for More Information
09:26 EDTCAHRBC Capital to hold a bus tour
Healthcare Bus Tour travels throughout Nashville, TN to visit with various healthcare companies on August 25-26.
09:13 EDTJPMOn The Fly: Pre-market Movers
Subscribe for More Information
07:28 EDTJPM, JPMJPMorgan upgraded to Buy from Outperform at CLSA
CLSA analyst Mike Mayo upgraded JPMorgan to Buy from Outperform with a $78 price target. Mayo said JPMorgan offers the most stable earnings of U.S. global banks for the past decade, a resilient balance sheet, and a dividend yield above the 10 year bond that implies outperformance 85% of the time historically.
August 24, 2015
18:02 EDTJPMS&P 500 enters correction territory amid global growth concerns
Subscribe for More Information
09:45 EDTBMYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Bank of America (BAC) upgraded to Outperform from Market Perform at Keefe Bruyette... Bristol-Myers (BMY) upgraded to Neutral from Underweight at Piper Jaffray... Chevron (CVX) upgraded to Neutral from Underperform at BofA/Merrill... Abercrombie & Fitch (ANF) upgraded to Overweight from Neutral... Nike (NKE) upgraded to Outperform from Market Perform at Telsey Advisory... DreamWorks (DWA) upgraded to Buy from Neutral at B. Riley... Caesarstone (CSTE) upgraded to Overweight from Equal Weight at Barclays... TransAlta (TAC) upgraded to Outperform from Market Perform at BMO Capital... Sarepta (SRPT) upgraded to Overweight from Neutral at Piper Jaffray... AutoZone (AZO) upgraded to Buy from Neutral at BofA/Merrill... Royal Dutch Shell (RDS.A) upgraded to Buy from Hold at Jefferies... Allscripts (MDRX) upgraded to Buy from Hold at Argus... China Unicom (CHU) upgraded to Buy from Hold at Jefferies... Ross Stores (ROST) upgraded to Buy from Neutral at Buckingham.
08:16 EDTBMYBristol-Myers, Pfizer to present new data on Eliquis at ESC Congress 2015
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) announced that 22 abstracts will be presented at the ESC Congress 2015, to be held August 29 to September 2 in London, United Kingdom. The new data reinforce the Alliance's commitment to the ongoing evaluation of Eliquis in both the nonvalvular atrial fibrillation and venous thromboembolism patient populations. In addition, data from the AEGEAN study evaluating adherence among NVAF patients further extends the Alliance's commitment to patient care.
07:34 EDTJPMJP Morgan volatility at high end of range
Subscribe for More Information
07:08 EDTBMYBristol-Myers upgraded to Neutral from Underweight at Piper Jaffray
Subscribe for More Information
August 23, 2015
12:35 EDTBMYBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use